Clinical Trials · NCT00365924

A Pilot Methodology Study To Evaluate Changes In Bone Quality Parameters Following Therapy With Forteo

Name: A Pilot Methodology Study To Evaluate Changes In Bone Quality Parameters Following Therapy With Forteo
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedN/ATeriparatide

Phase: N/A
Recruitment status: Completed
Sponsor: Pfizer
Enrollment: 20
Start date: Dec 2006
Locations: 3 sites, Argentina
Primary endpoint: Changes in bone quality parameters (micro- and macroarchitecture) in osteoporotic postmenopausal women following 12 months of therapy with Forteo

View Teriparatide compound reference